Effect of Nettles in treatment of diabetes
Phase 3
Recruiting
- Conditions
- Type 2 Diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20230313057707N1
- Lead Sponsor
- Kian Pharmed Parsian
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
Having diabetes type 2
Exclusion Criteria
Allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of people who have a fasting blood sugar level above 120 mg/dl. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting blood sugar test.
- Secondary Outcome Measures
Name Time Method HbA1C. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: HbA1C test.;Creatinine. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Creatinine test.;Fasting insulin. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting insulin test.;Cholesterol. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Cholesterol test.;Triglyceride. Timepoint: Blood test before starting the drug and three months later (after taking the drug completely). Method of measurement: Triglyceride test.